{"id":"https://openalex.org/W2002141786","doi":"https://doi.org/10.1038/eye.2001.214","title":"Rapid development of visual field defects associated with vigabatrin therapy","display_name":"Rapid development of visual field defects associated with vigabatrin therapy","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2002141786","doi":"https://doi.org/10.1038/eye.2001.214","mag":"2002141786","pmid":"https://pubmed.ncbi.nlm.nih.gov/11702991"},"language":"en","primary_location":{"id":"doi:10.1038/eye.2001.214","doi":"https://doi.org/10.1038/eye.2001.214","is_oa":false,"landing_page_url":"https://doi.org/10.1038/eye.2001.214","pdf_url":null,"source":{"id":"https://openalex.org/S167047176","display_name":"Eye","issn_l":"0078-5334","issn":["0078-5334","0950-222X","1476-5454"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002141786"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002533399","display_name":"Hayyam K\u0131ratl\u0131","orcid":"https://orcid.org/0000-0003-2100-4740","observed_orcids":["https://orcid.org/0000-0003-2100-4740"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Hayyam Kiratli","raw_affiliation_strings":["Department of Ophthalmology, Hacettepe University, School of Medicine, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Hacettepe University, School of Medicine, Ankara, Turkey","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030678173","display_name":"Peykan T\u00fcrk\u00e7\u00fco\u011flu","orcid":"https://orcid.org/0000-0002-9750-6213","observed_orcids":["https://orcid.org/0000-0002-9750-6213"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Peykan T\u00fcrk\u00e7\u00fco\u01e7lu","raw_affiliation_strings":["Department of Ophthalmology, Hacettepe University, School of Medicine, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Hacettepe University, School of Medicine, Ankara, Turkey","institution_ids":["https://openalex.org/I66514158"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002533399"],"corresponding_institution_ids":["https://openalex.org/I66514158"],"apc_list":{"value":3590,"currency":"USD","value_usd":3590},"apc_paid":null,"fwci":0.2851,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.5798722,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"15","issue":"5","first_page":"672","last_page":"674"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.07819999754428864,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/visual-field-defects","display_name":"visual field defects","score":0.9900000095367432},{"id":"https://openalex.org/keywords/visual-field-constriction","display_name":"visual field constriction","score":0.8180000185966492},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7329999804496765},{"id":"https://openalex.org/keywords/temporal-lobe-epilepsy","display_name":"temporal lobe epilepsy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-induced-visual-impairment","display_name":"drug-induced visual impairment","score":0.6570000052452087},{"id":"https://openalex.org/keywords/pediatric-epilepsy","display_name":"pediatric epilepsy","score":0.48100000619888306}],"concepts":[{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.9776526689529419},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6136101484298706},{"id":"https://openalex.org/C2776058522","wikidata":"https://www.wikidata.org/wiki/Q2364768","display_name":"Visual field","level":2,"score":0.5904388427734375},{"id":"https://openalex.org/C119767625","wikidata":"https://www.wikidata.org/wiki/Q618211","display_name":"Optometry","level":1,"score":0.41194576025009155},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.3526651859283447},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.22259747982025146},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.10528507828712463},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.0707617998123169}],"mesh":[{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004585","descriptor_name":"Electrooculography","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014794","descriptor_name":"Visual Fields","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D058609","descriptor_name":"Visual Field Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/eye.2001.214","doi":"https://doi.org/10.1038/eye.2001.214","is_oa":false,"landing_page_url":"https://doi.org/10.1038/eye.2001.214","pdf_url":null,"source":{"id":"https://openalex.org/S167047176","display_name":"Eye","issn_l":"0078-5334","issn":["0078-5334","0950-222X","1476-5454"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye","raw_type":"journal-article"},{"id":"pmid:11702991","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11702991","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye (London, England)","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2016655873","https://openalex.org/W2058677302","https://openalex.org/W2080221650","https://openalex.org/W2088132894","https://openalex.org/W2090232489","https://openalex.org/W2116602570"],"related_works":["https://openalex.org/W1986159818","https://openalex.org/W2004131639","https://openalex.org/W2116602570","https://openalex.org/W213483164","https://openalex.org/W1988302543","https://openalex.org/W2108760374","https://openalex.org/W2134063515","https://openalex.org/W2069603973","https://openalex.org/W2035892777","https://openalex.org/W2324946881"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}